Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Cynthia Rudin, PhD, is a highly regarded computer scientist who’s been eyeing the advance of artificial intelligence into society with equal parts enthusiasm and concern.
By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public.
The Senate Committee on Health, Education, Labor and Pensions has passed the last of 19 bipartisan pieces of legislation that will become the Senate companion to the 21st Century Cures Act–passed last year by the House of Representatives in a vote of 344-77.
BOSTON—The time is right for more and more people to have their genome sequenced, said Yaron Turpaz, PhD, MBA, CIO of Human Longevity, speaking at Bio-IT World on April 7.
A shocking 39 percent of potentially harmful drug orders weren’t flagged by a computerized physician order entry (CPOE) system designed to do just that, according to the latest report from The Leapfrog Group.
BOSTON—An interdisciplinary team was key to the successful implementation of interactive visualization within the EMR at The Ohio State University, said Randi Foraker, PhD, of the university’s College of Public Health, speaking at the Bio-IT World Congress on April 7.
Konica Minolta Business Innovation Center (BIC) has set its sights on digital health, launching a telemedicine pilot and announcing plans to seek investments and acquisitions.
The Robert Wood Johnson Foundation is holding the Mood Challenge for ResearchKit, calling upon researchers and technologists to submit proposals for ResearchKit studies that will further understanding of mood and how it relates to daily life.
A more highly individualized customer experience could drive revenue up by 16 percent, according to C-suite executives in a study conducted by Oracle.